Koki Ikeda returns with a reported world best—and two lost years

The distinction that matters is reported world best, not an already ratified world record. Yomiuri Shimbun and Monthly Athletics reported his time and its world-best status, but an official results sheet and international recognition of the mark have not been independently established. That qualification does not erase the scale of the performance; it separates what the race reports establish from what still needs formal confirmation.⁠1⁠3

France’s Gabriel Bordier had set the previous world best of 37:23.99 in August 2025. Eiki Takahashi’s Japanese record stood at 37:25.21, while Ikeda’s own best was 37:25.90; both Japanese marks dated to November 2020. Ikeda therefore took almost a minute off a personal best that had stood for six years, on a day when simply reaching the start line already represented a substantial victory.⁠3⁠6

This was a 25-lap track race, not the 20-kilometre road walk in which he won silver at the Tokyo Olympics held in 2021. His last competition had been the 10,000-metre walk at the national corporate championships in September 2024, after finishing seventh at that summer’s Paris Olympics. The comeback tested him over half his Olympic distance, in a very different setting.⁠3⁠6

He broke clear immediately and covered the opening 1,000 metres in 3:30. Afterwards, he acknowledged that he had gone out faster than intended and should have been more controlled. He settled, then pushed again late. He had prepared two or three levels of race plan: one aim was to turn the preceding weeks of preparation into a result; as the race developed, he began chasing the clock.⁠6

At the finish he smiled. Then the applause and calls of welcome brought tears. Monthly Athletics described an athlete rediscovering not just competition but the happiness it gave him—something his solitary training could preserve only in outline.⁠6

Only weeks earlier, on October 23, the Court of Arbitration for Sport had upheld Ikeda’s appeal against World Athletics. It ruled that he had not committed an anti-doping rule violation, set aside the disciplinary tribunal’s decision and ordered his immediate reinstatement, with no period of ineligibility. His four-year ban had not run its course or been reduced as an act of leniency. The decision underpinning it had been overturned.⁠11

The case began before Paris. In June 2024, World Athletics alleged blood manipulation on the basis of abnormalities in Ikeda’s Athlete Biological Passport, which tracks biological measurements over time. The disputed blood-test values came from June through August 2023. The alleged practice involved reinfusing previously collected blood; Ikeda consistently denied doping.⁠11⁠6

He was provisionally suspended in November 2024. On February 14, 2025, the disciplinary tribunal imposed four years of ineligibility, cancelled his results from June 20, 2023, and ordered medal forfeiture. He appealed in March 2025, and a hearing took place at CAS headquarters in Lausanne on May 11 and 12, 2026. The successful appeal also reversed the cancellation of his results, restoring performances including seventh place in Paris.⁠4⁠11⁠3

The appeal panel did not find that the passport values had been normal. Their abnormality was undisputed. Instead, it accepted that Ikeda had established several factors—including personal medical conditions—to explain them, and found his alternative physiological explanation plausible. CAS stressed that he had supplied extensive supporting evidence, not simply asserted his position.⁠11

That evidence was, the panel said, far more abundant and specific than the material before the original tribunal, giving it additional grounds for assessment. The available CAS account is a media summary, not the binding full award, and it does not identify the medical conditions. There is no basis to guess them. Its stated conclusion, however, is unambiguous: Ikeda did not violate the anti-doping rules.⁠11

His employer and athletics team, Asahi Kasei, supported the appeal after consulting him and medical and scientific specialists. That support mattered beyond the proceedings. Ikeda told Monthly Athletics that the people around him were fighting alongside him; with them still fighting, he could not be the first to give up.⁠4⁠6

During his exclusion, Ikeda trained alone along riversides and in gyms. Without races to work towards, motivation was difficult. He mentally followed the competition calendar, imagining the training blocks he would normally have been completing. The calendar kept moving even when his racing career could not.⁠6

His reaction to returning held gratitude and anger together. In comments reported by Yomiuri Shimbun, he made no attempt to suggest that a successful appeal or a spectacular time could restore what had gone.

He also said, in translation: “I was able to return because of the support of the people around me, and I am filled with gratitude.” He wants to repay that support through the rest of his athletic career. Those are compatible feelings, not competing versions of the comeback: relief at being able to race again does not require pretending the interruption cost him nothing.⁠1⁠6

The immediate sporting target was practical. Monthly Athletics reported a 40:00.00 qualifying standard over 10,000 metres for the 2027 Japanese half-marathon race-walking championships. His return time was comfortably inside it. But clearing that performance threshold is not the same as securing an entry, and neither is the same as winning national selection.⁠6

Ikeda wants to earn a representative place through the Japanese championships and pursue a medal at the 2027 World Championships in Beijing. Beyond that, his ambition remains Olympic and world championship gold. His next race date and the relevant 2027 national championship schedule have not been established, while formal recognition of the comeback mark remains unconfirmed.⁠1⁠6

The ruling restored his right to compete. The race showed what he could do with it. Neither guarantees the international return he wants, but he can now pursue it on a start line rather than in an appeal hearing.